http://www.onemedplace.com/blog/wp-content/uploads/2009/08/neopharm.jpg
NeoPharm, a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/08/tedkennedy.jpg
Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy's life, is one of the deadliest brain tumors that can occur in both adults and children.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/09/cancerdrugs.jpg
On 10/19/09, BioElectronics (OTC: BIEL.PK) announced the initial results from the pilot section of its ongoing acetaminophen comparison study.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/07/lungs-small.jpg
The drug candidate IL13-PE has the potential to be the first effective therapy for idiopathic pulmonary fibrosis (IPF), which kills an estimated 40,000 people in the United States each year.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/03/lungs.jpg
The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/07/handshake2.jpg
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
View Article
More Pages to Explore .....